雜志介紹

Expert Opinion On Drug Discovery雜志介紹

《Expert Opinion On Drug Discovery》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱關(guān)于藥物發(fā)現(xiàn)的專家意見，本刊主要出版、報道醫(yī)學(xué)-PHARMACOLOGY & PHARMACY領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為6，最新CiteScore 指數(shù)為10.2。

本刊近期中國學(xué)者發(fā)表的論文主要有：

• The discovery and design of novel HIV-1 capsid modulators and future perspectives

  Author: Ding, Dang; Xu, Shujing; Zhang, Xujie; Jiang, Xiangyi; Cocklin, Simon; Dick, Alexej; Zhan, Peng; Liu, Xinyong

• Latest developments in engineered skeletal muscle tissues for drug discovery and development

  Author: Ostrovidov, Serge; Ramalingam, Murugan; Bae, Hojae; Orive, Gorka; Fujie, Toshinori; Shi, Xuetao; Kaji, Hirokazu

• Targeting viral proteins for restraining SARS-CoV-2: focusing lens on viral proteins beyond spike for discovering new drug targets

  Author: Yang, Tao; Wang, Si Chun; Ye, Linyan; Maimaitiyiming, Yasen; Naranmandura, Hua

• Computational approaches for the design of modulators targeting protein-protein interactions

  Author: Rehman, Ashfaq Ur; Khurshid, Beenish; Ali, Yasir; Rasheed, Salman; Wadood, Abdul; Ng, Ho-Leung; Chen, Hai-Feng; Wei, Zhiqiang; Luo, Ray; Zhang, Jian

英文介紹

Expert Opinion On Drug Discovery雜志英文介紹

Expert Opinion on Drug Discovery (ISSN 1746-0441 [print], 1746-045X [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on novel technologies involved in the drug discovery process, leading to new leads and reduced attrition rates. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.

The Editors welcome:

Reviews covering chemoinformatics; bioinformatics; assay development; novel screening technologies; in vitro/in vivo models; structure-based drug design; systems biology

Drug Case Histories examining the steps involved in the preclinical and clinical development of a particular drug

The audience consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and other closely related professionals looking to enhance the success of their drug candidates through optimisation at the preclinical level.